Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Advanced Non-small Cell Lung Cancer × Platinum Compounds × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Ovarian Neoplasms 1 Glioma 1 Advanced Non-small Cell Lung Cancer 1

Interventions

nazartinib 1 Platinum Compounds 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05416775 2022-08-19

Phase Ib/II Study of SHR-8068 Injection in the Treatment of Advanced Non-small Cell Lung Cancer

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 1/2 Recruiting

Advanced Non-small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡